Abiopharma

POLYRIZON LTD. (PLRZ)

Symbol	PLRZ
Name	POLYRIZON LTD.
Sector	HEALTH CARE
Region	Middle East
Industry	Biotechnology: Pharmaceutical Preparations
Address	8 HA-PNINA STREET, RAANANA, 4321545, United States
Telephone	972-54-7979668
Fax	—
Email	—
Website	https://www.polyrizon-biotech.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001893645
Description	Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a "biological mask" with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Additional info from NASDAQ: Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a "biological mask" with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs.

2026-07-02 11:32

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial

2026-06-29 12:44

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

2026-06-17 12:15

Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform

2026-06-15 12:05

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

2026-06-08 13:25

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial

2026-05-13 13:25

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

2026-05-05 07:07

New Form EFFECT - Polyrizon Ltd. Filed: 2026-05-04 AccNo: 9999999995-26-001475 Size: 1 KB

2026-05-04 12:53

POLYRIZON LTD. (PLRZ) Files Form 6-K

2026-05-04 12:45

Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform

2026-04-30 17:58

New Form F-1/A - Polyrizon Ltd. Filed: 2026-04-30 AccNo: 0001213900-26-050347 Size: 116 KB

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT07588672	Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker C…	Na	Seasonal Allergic Rhinitis (SAR)	Not_Yet_Recruiting	2026-07-15	2027-09-30	ClinicalTrials.gov

Total clinical trials: 1

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672

Total products: 16